These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 11158607)
21. Comprehensive allelotyping of human renal cell carcinomas using microsatellite DNA probes. Thrash-Bingham CA; Greenberg RE; Howard S; Bruzel A; Bremer M; Goll A; Salazar H; Freed JJ; Tartof KD Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2854-8. PubMed ID: 7708737 [TBL] [Abstract][Full Text] [Related]
22. Histopathological, cytogenetic, and molecular characterization of renal cortical tumors. Presti JC; Rao PH; Chen Q; Reuter VE; Li FP; Fair WR; Jhanwar SC Cancer Res; 1991 Mar; 51(5):1544-52. PubMed ID: 1671759 [TBL] [Abstract][Full Text] [Related]
23. Introduction of normal chromosome 3p modulates the tumorigenicity of a human renal cell carcinoma cell line YCR. Shimizu M; Yokota J; Mori N; Shuin T; Shinoda M; Terada M; Oshimura M Oncogene; 1990 Feb; 5(2):185-94. PubMed ID: 1969617 [TBL] [Abstract][Full Text] [Related]
24. A human gene that restores the DNA-repair defect in SCID mice is located on 8p11.1-->q11.1. Kurimasa A; Nagata Y; Shimizu M; Emi M; Nakamura Y; Oshimura M Hum Genet; 1994 Jan; 93(1):21-6. PubMed ID: 8270250 [TBL] [Abstract][Full Text] [Related]
25. Patterns of specific genomic alterations associated with poor prognosis in high-grade renal cell carcinomas. Glukhova L; Angevin E; Lavialle C; Cadot B; Terrier-Lacombe MJ; Perbal B; Bernheim A; Goguel AF Cancer Genet Cytogenet; 2001 Oct; 130(2):105-10. PubMed ID: 11675130 [TBL] [Abstract][Full Text] [Related]
26. Direct molecular analysis of a deletion of 3p in tumors from patients with sporadic renal cell carcinoma. van der Hout AH; Kok K; van den Berg A; Oosterhuis JW; Carritt B; Buys CH Cancer Genet Cytogenet; 1988 Jun; 32(2):281-5. PubMed ID: 2835149 [TBL] [Abstract][Full Text] [Related]
27. Combined LOH/CGH analysis proves the existence of interstitial 3p deletions in renal cell carcinoma. Alimov A; Kost-Alimova M; Liu J; Li C; Bergerheim U; Imreh S; Klein G; Zabarovsky ER Oncogene; 2000 Mar; 19(11):1392-9. PubMed ID: 10723130 [TBL] [Abstract][Full Text] [Related]
28. PCR-based RFLP screening of the commonly deleted 3p loci in renal cortical neoplasms. el-Naggar AK; Batsakis JG; Wang G; Lee MS Diagn Mol Pathol; 1993 Dec; 2(4):269-76. PubMed ID: 7906993 [TBL] [Abstract][Full Text] [Related]
29. Growth and transformation suppressor genes for BHK Syrian hamster cells on human chromosomes 1 and 11. Annab LA; Dong JT; Futreal PA; Satoh H; Oshimura M; Barrett JC Mol Carcinog; 1992; 6(4):280-8. PubMed ID: 1485918 [TBL] [Abstract][Full Text] [Related]
30. Detection of deletions in the short arm of chromosome 3 in uncultured renal cell carcinomas by interphase cytogenetics. Siebert R; Jacobi C; Matthiesen P; Zühlke-Jenisch R; Potratz C; Zhang Y; Stöckle M; Klöppel G; Grote W; Schlegelberger B J Urol; 1998 Aug; 160(2):534-9. PubMed ID: 9679924 [TBL] [Abstract][Full Text] [Related]
31. Major role for a 3p21 region and lack of involvement of the t(3;8) breakpoint region in the development of renal cell carcinoma suggested by loss of heterozygosity analysis. van den Berg A; Hulsbeek MF; de Jong D; Kok K; Veldhuis PM; Roche J; Buys CH Genes Chromosomes Cancer; 1996 Jan; 15(1):64-72. PubMed ID: 8824727 [TBL] [Abstract][Full Text] [Related]
32. Physical and functional mapping of a tumor suppressor locus for renal cell carcinoma within chromosome 3p12. Lott ST; Lovell M; Naylor SL; Killary AM Cancer Res; 1998 Aug; 58(16):3533-7. PubMed ID: 9721855 [TBL] [Abstract][Full Text] [Related]
33. Modeling non-random deletions in cancer. Kost-Alimova M; Imreh S Semin Cancer Biol; 2007 Feb; 17(1):19-30. PubMed ID: 17174104 [TBL] [Abstract][Full Text] [Related]
34. Recurrent deletion of the short arm of chromosome 3 in human renal cell carcinoma: shift of the c-raf 1 locus. Teyssier JR; Henry I; Dozier C; Ferre D; Adnet JJ; Pluot M J Natl Cancer Inst; 1986 Dec; 77(6):1187-95. PubMed ID: 3467112 [TBL] [Abstract][Full Text] [Related]
35. Novel tumor suppressor locus in human chromosome region 3p14.2. Jülicher K; Marquitan G; Werner N; Bardenheuer W; Vieten L; Bröcker F; Topal H; Seeber S; Opalka B; Schütte J J Natl Cancer Inst; 1999 Sep; 91(18):1563-8. PubMed ID: 10491433 [TBL] [Abstract][Full Text] [Related]
36. Functional evidence for involvement of multiple putative tumor suppressor genes on the short arm of chromosome 3 in human oral squamous cell carcinogenesis. Uzawa N; Yoshida MA; Hosoe S; Oshimura M; Amagasa T; Ikeuchi T Cancer Genet Cytogenet; 1998 Dec; 107(2):125-31. PubMed ID: 9844607 [TBL] [Abstract][Full Text] [Related]
37. An integrated physical and gene map of the 3.5-Mb chromosome 3p21.3 (AP20) region implicated in major human epithelial malignancies. Protopopov A; Kashuba V; Zabarovska VI; Muravenko OV; Lerman MI; Klein G; Zabarovsky ER Cancer Res; 2003 Jan; 63(2):404-12. PubMed ID: 12543795 [TBL] [Abstract][Full Text] [Related]
38. Molecular and cellular characterization of human renal cell carcinoma cell lines. Anglard P; Trahan E; Liu S; Latif F; Merino MJ; Lerman MI; Zbar B; Linehan WM Cancer Res; 1992 Jan; 52(2):348-56. PubMed ID: 1345811 [TBL] [Abstract][Full Text] [Related]
39. The distal region of the long arm of human chromosome 1 carries tumor suppressor activity for a human fibrosarcoma line. Klein KG; Bouck NP Cancer Genet Cytogenet; 1994 Apr; 73(2):109-21. PubMed ID: 8174085 [TBL] [Abstract][Full Text] [Related]
40. Coincidence of synteny breakpoints with malignancy-related deletions on human chromosome 3. Kost-Alimova M; Kiss H; Fedorova L; Yang Y; Dumanski JP; Klein G; Imreh S Proc Natl Acad Sci U S A; 2003 May; 100(11):6622-7. PubMed ID: 12738884 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]